Private company
Bright Green Corp
Bright Green Corp is an American medicinal chemicals and botanical products company based in Grants.1
Last updated Oct 21, 2026.
Overview
- IndustryMedicinal Chemicals & Botanical Products1
- HeadquartersFt. Lauderdale, Florida1
- Incorporated inDE2
- Business address401 East Las Olas Blvd., Suite 1400, Ft. Lauderdale, Fl 333012
- Filer category, Emerging growth company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
U.S. Our DEA Registration permits our cannabis activities under federal law, which sets BGC apart from most other U.S. cannabis companies.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Financial statements
| Fiscal year | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | $05 | $05 | $04 | |
| Operating expenses | $2.5M5 | $27.3M4 | $8.9M4 | |
| Operating income | -$2.5M5 | -$27.3M4 | -$8.9M4 | |
| Income before tax | -$2.5M5 | -$27.5M4 | -$12.9M4 | |
| Net income | -$2.5M5 | -$27.7M4 | -$13.1M4 | |
| Earnings per share | -$0.025 | -$0.174 | -$0.074 | |
| Earnings per share (diluted) | -$0.174 | -$0.074 | ||
| Shares (weighted, basic) | 156.8M shares5 | 162.1M shares4 | 178.6M shares4 | |
| Shares (weighted, diluted) | 162.1M shares4 | 178.6M shares4 |
| Fiscal year | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Current assets | $1.5M5 | $492.4K4 | $268.3K4 | |
| Property, plant and equipment | $7.3M5 | $17.1M4 | $16.4M4 | |
| Intangible assets | $1.0K5 | $1.0K4 | $1.0K4 | |
| Total assets | $8.8M5 | $22.8M4 | $17.4M4 | |
| Accounts payable | $149.9K5 | $5.0M4 | $4.2M4 | |
| Current liabilities | $168.0K5 | $7.5M4 | $6.2M4 | |
| Long-term liabilities | $392.2K5 | $3.7M4 | $201.8K4 | |
| Total liabilities | $560.2K5 | $11.2M4 | $6.4M4 | |
| Retained earnings | -$6.4M5 | -$34.1M4 | -$47.2M4 | |
| Shareholders’ equity | $7.2M5 | $8.2M4 | $11.6M4 | $11.0M4 |
| Shares outstanding | 157.5M shares5 | 173.3M shares4 | 184.8M shares4 |
Corporate structure
Bright Green Corp sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Bright Green Corp
- Lynn Stockwell Filed SC 13D/A on Bright Green Corp, latest Sep 6, 2023 (2 filings since Jun 15, 2023)
- E. Mailloux Enterprises, Inc. Filed SC 13G/A on Bright Green Corp, latest Jun 12, 2023 (2 filings since Jun 3, 2022)
- Terry Rafih Filed SC 13D on Bright Green Corp, latest Dec 22, 2022
- Bright Green Corp Ft. Lauderdale, Florida
- ALTEROLA BIOTECH INC. Stake · Birkenhead Merseyside, United Kingdom
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.
What it owns
What Bright Green Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Land | $260.0K4 Dec 31, 2023 | $260.0K4 Dec 31, 2022 | 0% |
| Buildings and improvements | $8.9M4 Dec 31, 2023 | $8.9M4 Dec 31, 2022 | 0% |
| Furniture and fixtures | $88.7K4 Dec 31, 2023 | $88.7K4 Dec 31, 2022 | 0% |
| Construction in progress | $10.6M4 Dec 31, 2023 | $10.7M4 Dec 31, 2022 | −0.9% |
| Property and equipment, before depreciation | $19.9M4 Dec 31, 2023 | $20.0M4 Dec 31, 2022 | −0.5% |
| Accumulated depreciation | $3.5M4 Dec 31, 2023 | $2.8M4 Dec 31, 2022 | +22.6% |
| Property and equipment, net | $16.4M4 Dec 31, 2023 | $17.1M4 Dec 31, 2022 | −4.3% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Stakes in other companies (equity method) | $4.0M4 Dec 31, 2022 |
Intangibles and goodwill
Leadership
Who has led Bright Green Corp, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
- Chief executive officerSeamus McAuley Feb 28, 2023 to Jun 5, 20239
- Chief executive officerEdward A. Robinson May 13, 2022 to May 13, 202210
- Chief executive officerTerry Rafih Dec 14, 2022 to Feb 14, 202311
- ChairTerry Rafih Feb 14, 2023 to Feb 20, 202412
- Chief financial officerSaleem Elmasri May 13, 2022 to Sep 11, 202413
Board members and other officers (7)
- Board memberSean Deson Mar 18, 2024 to Sep 9, 202414
- Board memberAlfie Morgan May 13, 2022 to Nov 21, 202315
- Board memberDean Vallore May 13, 2022 to May 28, 202416
- Board memberEdward A. Robinson May 13, 2022 to May 13, 202210
- Board memberLynn Stockwell May 13, 2022 to Jun 10, 202417
- Board memberRobert Arnone May 13, 2022 to May 28, 202418
- Board memberTerry Rafih May 13, 2022 to Dec 14, 202219
Named in SEC Form D filings
People the company listed in its private-offering notices.
- DirectorDean Valore named Sep 22, 2022 to Jun 5, 202320
Timeline
- Mar 21, 20258-K Regulation FD disclosure21
- Feb 27, 20258-K Entered a material agreement; Bankruptcy or receivership22
- Jan 28, 20258-K Entered a material agreement; Bankruptcy or receivership23
- Dec 27, 20248-K Executive or director change; Regulation FD disclosure24
- Nov 18, 20248-K Shareholder vote25
- Sep 18, 20248-K Entered a material agreement; New debt or obligation; Unregistered sale of shares26
- Aug 19, 20248-K Entered a material agreement; New debt or obligation; Listing notice or transfer27
- May 30, 20248-K Other events28
- Apr 3, 20248-K Entered a material agreement; Executive or director change29
- Mar 19, 20248-K Entered a material agreement; Completed an acquisition or sale; New debt or obligation30
- Mar 11, 20248-K Entered a material agreement; Executive or director change31
- Feb 22, 20248-K Regulation FD disclosure32
- Feb 28, 2023New chief executive Seamus McAuley becomes CEO9
- Dec 14, 2022New chief executive Terry Rafih becomes CEO11
- May 13, 2022New chief executive Edward A. Robinson becomes CEO10
Calendar
When it reported results
- Aug 17, 2023Reported quarterly or annual results33
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
159 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 28 major events, 39 insider forms, 5 large holders, 2 private raises, 72 other. The latest 20:
- Apr 1, 2025NT 10-K EDGAR
- Mar 21, 20258-K EDGAR
- Feb 27, 20258-K EDGAR
- Jan 28, 20258-K EDGAR
- Dec 27, 20248-K EDGAR
- Nov 19, 202410-Q EDGAR
- Nov 18, 20248-K EDGAR
- Nov 14, 2024NT 10-Q EDGAR
- Oct 18, 2024DEF 14A EDGAR
- Oct 4, 2024PRER14A EDGAR
- Sep 18, 20248-K EDGAR
- Sep 18, 2024PRE 14A EDGAR
- Sep 11, 20244 EDGAR
- Sep 10, 20244 EDGAR
- Sep 9, 2024144 EDGAR
- Sep 9, 20244/A EDGAR
- Sep 9, 20244/A EDGAR
- Sep 6, 2024144 EDGAR
- Sep 5, 2024144 EDGAR
- Sep 5, 20244 EDGAR
The 159 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
8 open-market trades by officers, directors and large owners since October 2021: 1 buys and 7 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | Elmasri SaleemChief Financial Officer | Sale | 13,263 | $0.19 | $2.5K | Form 4 |
| Sep 9, 2024 | Elmasri SaleemChief Financial Officer | Sale | 12,679 | $0.19 | $2.4K | Form 4 |
| Sep 6, 2024 | Elmasri SaleemChief Financial Officer | Sale | 14,598 | $0.20 | $2.9K | Form 4 |
| Sep 5, 2024 | Elmasri SaleemChief Financial Officer | Sale | 57,211 | $0.20 | $11.4K | Form 4 |
| Sep 3, 2024 | Elmasri SaleemChief Financial Officer | Sale | 398,773 | $0.20 | $79.8K | Form 4 |
| Jun 5, 2024 | Stockwell LynnDirector | Sale | 1,000,000 | $0.36 | $360.0K | Form 4 |
| Sep 10, 2023 | Elmasri SaleemChief Financial Officer | Buy | 500,000 | Form 4 | ||
| Aug 31, 2023 | Stockwell LynnDirector | Sale | 250,000 | $0.47 | $117.5K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Lynn StockwellSC 13D/A, 2 filings Jun 15, 2023 to Sep 6, 202334
- E. Mailloux Enterprises, Inc.SC 13G/A, 2 filings Jun 3, 2022 to Jun 12, 202335
- Terry RafihSC 13D, 1 filing Dec 22, 202236
Stakes it holds
Bright Green Corp has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).
- ALTEROLA BIOTECH INC.SC 13D Oct 13, 202237
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $13.5M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2023 | $3.5M | $3.5M |
| 2022 | $10.0M | $10.0M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
SEC filer profile
How Bright Green Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBright Green Corp1
- CIK0001886799
- Filer status<br>emerging growth company1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address401 East Las Olas Blvd., Suite 1400, Ft. Lauderdale, FL 333011
- Phone(201)370-11401
- Shares outstanding191,166,318 as of Nov 19, 20248
- Public float$75.1M as of Jun 30, 202339
- On EDGAR sinceOct 12, 20211
- Filings162 in all: 8-K (28), 4 (23), 3 (12), 10-Q (9), CORRESP (7), EFFECT (7), UPLOAD (7), 424B3 (6)1
All 37 form types
NT 10-Q (6), POS AM (6), S-1/A (6), 144 (5), 4/A (3), DEF 14A (3), NT 10-K (3), S-1 (3), SC 13D (3), 10-K (2), 5 (2), D (2), DRSLTR (2), PRE 14A (2), 10-K/A (1), 10-Q/A (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), DRS/A (1), PRER14A (1), RW (1), S-3 (1), S-8 (1), SC 13D/A (1), SC 13G (1), SC 13G/A (1)
- Latest filingsAnnual report (10-K) Apr 16, 2024
Quarterly report (10-Q) Nov 19, 2024
Proxy statement (DEF 14A) Oct 18, 2024
Latest 8-K (8-K) Mar 21, 2025
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARTerry Rafih, Chief executive officer
- 12SEC EDGARTerry Rafih, Chair
- 13
- 14SEC EDGARSean Deson, Board member
- 15SEC EDGARAlfie Morgan, Board member
- 16SEC EDGARDean Vallore, Board member
- 17SEC EDGARLynn Stockwell, Board member
- 18SEC EDGARRobert Arnone, Board member
- 19SEC EDGARTerry Rafih, Board member
- 20
- 21SEC EDGARRegulation FD disclosure
- 22
- 23
- 24
- 25SEC EDGARShareholder vote
- 26
- 27
- 28SEC EDGAROther events
- 29
- 30
- 31
- 32SEC EDGARRegulation FD disclosure
- 33
- 34
- 35
- 36
- 37
- 38
- 39